MeSH D009069 - movement disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D002493:Central nervous system diseases
0 Companies
0 Drugs
Success rate
D009069:
Movement disorders
D006211:Pantothenate kinase-associated neurodegeneration
0 Companies
0 Drugs
Success rate
D006527:Hepatolenticular degeneration
D013494:Progressive supranuclear palsy
0 Companies
0 Drugs
Success rate
D013981:Tic disorders
D017109:Drug-induced akathisia
D017204:Angelman syndrome
0 Companies
0 Drugs
Success rate
D019578:Multiple system atrophy
0 Companies
0 Drugs
Success rate
D020329:Essential tremor
D020820:Dyskinesias
D020821:Dystonic disorders
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
67%2/3
Phase 2
21%4/19
Phase 3
20%1/5
Approved: 1Overall Success rate: 3%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use